Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ConocoPhillips (COP) vs Invesco Ltd. (IVZ) Price & Performance

ConocoPhillipsTrade
Invesco Ltd.Trade

Price performance (Past 24H)

Key statistics

ConocoPhillips vs Invesco Ltd. — how do they compare? ConocoPhillips trades at $125.33 (market cap $151.27B), while Invesco Ltd. trades at $31.16 (market cap $13.85B). The key difference: ConocoPhillips is far larger — about 10.9× Invesco Ltd.'s market cap, and Invesco Ltd. pays the higher dividend (2.74%). Which is the better fit depends on your goals.

COPIVZ
Market Cap
$151.27B$13.85B
Sector
EnergyFinancials
52-Week High
$133.80$32.01
52-Week Low
$85.66$20.67
Enterprise Value
$166.87B$24.01B
Dividend Yield
2.67%2.74%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About ConocoPhillips

ConocoPhillips is a U.S.-based independent exploration and production firm. In 2021, it produced 1.0 million barrels per day of oil and natural gas liquids and 3.2 billion cubic feet per day of natural gas, primarily from Alaska and the Lower 48 in the United States and Norway in Europe and several countries in Asia-Pacific and the Middle East. Proven reserves at year-end 2021 were 6.1 billion barrels of oil equivalent.

Read more on COP

About Invesco Ltd.

Invesco provides investment-management services to retail (65% of managed assets) and institutional (35%) clients. At the end of August 2022, the firm had $1.416 trillion in assets under management spread among its equity (47% of AUM), balanced (5%), fixed-income (22%), alternative investment (14%), and money market (12%) operations. Passive products account for 32% of Invesco's total AUM, including 56% of the company's equity operations and 13% of its fixed-income platform. Invesco's U.S. retail business is one of the 10 largest nonproprietary fund complexes in the country. The firm also has a meaningful presence outside the U.S., with close to one third of its AUM sourced from Canada (2%), the U.K. (4%), continental Europe (11%), and Asia (15%).

Read more on IVZ